bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.02.26.640401

Multi-omics highlights challenges in assessing the composition and performance of microbial consortia for commercial applications

Abstract

The use of commercial microbial consortia in bioremediation is a promising method for addressing environmental pollution. These consortia are comprised of complex communities that include unculturable species that make it challenging to optimize consortia performance and carry out risk assessments for regulatory purposes. In this study, we provide a framework for using multi-omics to monitor the composition and performance of an aerobic ammonia oxidizing consortium in development for wastewater treatment. Long-read sequencing showed the consortium was dominated by an unclassified Nitrosospira species with the capacity for ammonia oxidation with many lower abundance taxa displaying the potential for denitrification. Considerable shifts in community composition and nitrogen cycling occurred when the consortium was grown along a redox gradient representative of wastewater for eight weeks. All aerobic and anaerobic cultures produced ammonia during the first four weeks and only aerobic cultures decreased ammonia concentrations after that time. Shotgun metagenomic sequencing showed the key ammonia oxidizing Nitrosospira sp. population decreased in abundance in aerobic cultures yet remained dominant in anaerobic cultures. Shotgun metatranscriptomic sequencing revealed that aerobic cultures decreased ammonia oxidation activity during the incubation and taxa that precluded detection in the starting material likely contributed to denitrification in anaerobic cultures. Metatranscriptomics showed that deamination of amino acids was an unexpected contributor to ammonia production that could negatively affect consortium performance. This study highlights how multi-omics provides insights that can be used to optimize performance and carry out risks assessments for consortia applied in different environmental settings. ImportanceThe use of microbial consortia from diverse environments is gaining traction in terms of advancing a more sustainable bioeconomy. Optimizing consortia for different applications and ensuring they are compliant with environmental regulations is difficult because current practices rely on growing microbes with unknown physiological requirements. In this study we apply leading-edge sequencing approaches to develop a framework that addresses these challenges using a consortium in development for ammonia removal from wastewater. We demonstrate that long-read DNA sequencing provides complete genome assemblies and functional insights into key populations involved in ammonia removal that are poorly represented in taxonomic databases. We show that coupling DNA to RNA sequencing provides valuable information on changes in composition and metabolic activity that can occur under environmentally representative conditions for wastewater. Ultimately, our approach serves as an example of cutting-edge genomics applications for stakeholders to consider in developing microbial consortia for safe and effective use across diverse applications.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Smith, D. D. N., Subasinghe, R. M., Kehoe, C., Gregoire, D. S.. 2025-03-01. Multi-omics highlights challenges in assessing the composition and performance of microbial consortia for commercial applications. https://doi.org/10.1101/2025.02.26.640401

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗